Hydrafacial's new exosome booster will be available early next year.
Organicell is a clinical-stage biopharmaceutical company focused on developing innovative biological therapeutics and regenerative medicine.
Organicell's science team will work with Hydrafacial to prove the efficacy of how this new booster application may reduce inflammation, increase collagen, and increase elastin.
"This partnership is the first of many we are working on in the aesthetic and hair space," said Organicell's CEO, Matt Sinnreich.